Numbers

Daqo trades at 0.29x book value with a negative enterprise value — the market is pricing its $3.4B polysilicon plant portfolio at close to zero and discounting $1.9B of cash on hand. The single metric that will rerate or derate this stock is the polysilicon spot price: at $5–6/kg DQ burns cash below cost; above $8–10/kg it returns to the 40–60% gross margins that made it a supercycle winner in 2021–2022. Everything in this page flows from whether you believe the commodity cycle turns before the cash runs out.

At a Glance

Share Price (Apr 30)

$19.22

Market Cap ($M)

1,301

Book Value / Share

$65.43

Price / Book

0.29

Enterprise Value ($M)

-640

Cash / Share

$28.70

Revenue and Earnings Power

Loading...

Revenue rose 15x from $302M (FY2018) to $4.6B (FY2022) on the polysilicon supercycle, then collapsed 86% as spot prices fell from $39/kg to under $6/kg — a textbook commodity pork cycle where capacity expansion massively overshot demand.

Loading...

At peak (FY2022), DQ earned 74% gross margins — polysilicon was scarce and priced at $30–39/kg. Today polysilicon trades at $5–6/kg, below DQ's cash cost, producing negative gross margins for six consecutive quarters.

Quarterly Trend — How Deep Is the Trough?

Loading...

Q1 2026 revenue collapsed to $27M — DQ produced 43,402 MT of polysilicon but sold only 4,482 MT (88% sales drop QoQ). Management is stockpiling inventory rather than selling below cost, a rational but cash-burning strategy. Losses narrowed to -$7M in Q4 2025 before the Q1 stockpiling decision deepened them to -$88M.

Cash Generation — Are Earnings Real?

Loading...

In profitable years (FY2020–2023), cash conversion was strong: cumulative OCF of $4.9B vs cumulative NI of $4.1B — a healthy 120% conversion. FY2021 OCF lagged NI due to receivables buildup from rapid revenue growth. In the downturn, OCF and NI have tracked closely — no accounting games, just real commodity-driven losses.

Loading...

DQ spent $2.7B on capex in FY2022–2023 expanding its Baotou (Inner Mongolia) facility — capacity doubled from ~77,000 MT to ~205,000 MT. That expansion is now complete and capex has dropped to $173M (FY2025), which is below D&A of $240M. The plant is built; the question is whether demand will ever fill it at a price above cash cost.

Capital Allocation

Loading...

DQ bought back $611M of shares in FY2022–2023, reducing share count from 78.2M to 65.7M (16% reduction). SBC totaled $605M over the same period — partially offsetting the buybacks. Net shares are down modestly from the peak but the SBC burden during profitable years was unusually high (6.7% of revenue in FY2022). Buybacks have stopped in the downturn.

Balance Sheet — The Fortress That Matters

Loading...

DQ paid off all debt by FY2021 and has carried zero debt since. Cash peaked at $3.5B (FY2022) and has declined to $1.9B — consumed by continued capex, buybacks, and operating losses. At the current quarterly cash burn rate (~$50–90M), the cash runway extends 5–8 years, though burn rate depends heavily on the inventory stockpiling strategy.

Cash ($M)

1,942

Total Debt ($M)

0

Current Ratio

5.37

Zero debt, $1.9B cash, current ratio 5.4x. By any traditional measure, this balance sheet can survive a prolonged downturn. The risk is not insolvency but slow book-value erosion from ongoing operating losses and potential asset impairments on the $3.4B PP&E.

Valuation — Price to Book Over Time

Loading...

Current P/B

0.29

5-Year Avg P/B

0.75

All-Time Avg P/B

1.41

P/E is not meaningful with negative earnings. For cyclical commodity producers like DQ, P/B is the anchor valuation metric. The stock peaked at 5.5x book in FY2020 when polysilicon was scarce; today at 0.29x, the market implies two-thirds of the balance sheet equity has no recoverable value.

Valuation Multiples History

Loading...

In profitable years (FY2021–2023), DQ traded at 1.7–4.6x P/E and 0.4–2.2x EV/EBITDA — extremely cheap even then. The market never awarded a premium multiple because it correctly anticipated the commodity bust. Today both metrics are negative and meaningless. EV/Sales at 2.35x (FY2025) overstates actual enterprise value since EV is negative on trailing figures.

Returns on Capital

Loading...

Peak ROIC of 80% (FY2022) reflected the supercycle — genuine earnings, not financial engineering. Now negative. The question is whether DQ can return to even 10–15% ROIC, which would make the stock enormously cheap at 0.29x book. A 12% ROE on $5.9B equity = $710M net income = $10.50/share earnings = roughly 2x current price.

Peer Comparison

No Results

Peer financial data is limited in this dataset. The key differentiator: DQ carries zero debt vs CSIQ's 1.8x D/E. In a prolonged downturn, balance sheet strength is the primary survival factor. DQ's $1.9B cash hoard is its moat against industry shakeout. Among pure-play polysilicon producers (Tongwei, GCL, Xinte), DQ's cost position (~$6–7/kg all-in) is mid-tier; Tongwei is the lowest-cost producer.

Fair Value and Scenario Analysis

No Results

Bear Case

$12

Base Case

$25

Bull Case

$50

Analyst consensus target: $22.78–$25.59. Range: $15 (Roth MKM) to $37 (Citigroup). GLJ Research downgraded to Sell at $18.13 in February 2026. The key variable is not DQ-specific execution but the commodity price: polysilicon at $5/kg means everyone loses; at $12/kg DQ earns $5+/share.

What the Numbers Say

The numbers confirm that DQ is a low-cost commodity producer sitting on a fortress balance sheet — $1.9B cash, zero debt, and the capacity to outlast weaker competitors in a prolonged oversupply crisis. They contradict any narrative that this is a growth stock or a technology play: it is pure commodity exposure, and the 86% revenue decline from peak proves that no amount of operational excellence can overcome a 75% collapse in your selling price. Watch polysilicon spot prices (currently CNY 35–37/kg in China, ~$5–7/kg internationally) and quarterly production/sales volume divergence — Q1 2026's decision to produce 43,000 MT but sell only 4,500 MT signals management is betting on a price recovery and willing to burn cash to avoid locking in below-cost sales; if that bet is wrong, book value erodes faster than the P/B discount can protect you.